34 filings
Page 2 of 2
8-K
bbh8w
5 Aug 21
Codiak BioSciences Reports Second Quarter 2021 Financial Results and Operational Progress
4:08pm
8-K
vuub6hb614vbmgygdv
6 Jul 21
Departure of Directors or Certain Officers
5:01pm
8-K
nnws7v czc3
23 Jun 21
Submission of Matters to a Vote of Security Holders
4:05pm
8-K
6xe1s00c lqrqhq
20 May 21
Departure of Directors or Certain Officers
5:00pm
8-K
ghoypb42xyncw4
10 May 21
Codiak Appoints Jennifer Wheler, M.D., as Chief Medical Officer
5:18pm
8-K
06a16fl zjef
6 May 21
Codiak BioSciences Reports First Quarter 2021 Financial Results and Operational Progress
4:10pm
8-K
3ai ao7sn
8 Apr 21
Regulation FD Disclosure
4:05pm
8-K
l3eunlrge
26 Mar 21
Departure of Directors or Certain Officers
4:05pm
8-K
b53faxotsks vrn
17 Mar 21
Codiak BioSciences Reports Fourth Quarter and Full Year 2020 Financial Results
7:44am
8-K
mwkzngjbm4mc9
8 Mar 21
Departure of Directors or Certain Officers
5:18pm
8-K
xmyewv bf58d58iavgn
4 Feb 21
Codiak Reports Additional Positive Phase 1 Results for exoIL-12™ Confirming
8:46am
8-K
pfchqfixay9f9ittvn
26 Jan 21
Departure of Directors or Certain Officers
4:39pm
8-K
il3rm6 3wroqtkq4
30 Dec 20
Codiak Reports Positive Initial Phase 1 Results for exoIL-12™ Demonstrating Tolerability and Absence of Systemic IL-12 Exposure in Healthy Volunteers
8:00am
8-K
saxpwzqfn14g8epkat0
20 Nov 20
Codiak BioSciences Reports Third Quarter 2020 Financial Results and Operational Progress
4:32pm